Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

Ya Hwee Tan, MBBS, MRCP, Siqin Zhou, MSc, Liu Xin, Soon Thye Lim, MBBS, MRCP, FAMS, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Daryl Tan, MBBS, MRCP, Michelle Poon, MBBS, MRCP, FRCPATH, Mohamad Farid, MBBS, MMed, MRCP, Colin Phipps Diong, Yuh Shan Lee, Shin-Yeu Ong, MD, Nicholas Francis Grigoropoulos, Kheng Wei Yeoh, MBBS, MSc, MRCP, MPH, FRCR (Clinical Oncology), Nagavalli Somasundaram, MBBS, MRCP, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Jason Yongsheng Chan, MBBS, MRCP, Esther Wei Yin Chang, MD MRCP, Tiffany Tang, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 5274.

https://doi.org/10.1182/blood-2019-125085

Published: 2019

Journal Articles

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients

Blood (2018) 132 (Supplement 1): 4111.

https://doi.org/10.1182/blood-2018-99-113952

Published: 2018

Journal Articles

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era

Ryan Mao Heng Lim, Natalie Pei Xin Chan, Lay Poh Khoo, BSc, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Leonard Tan, MBBS, MRCPath, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Nagavalli Somasundaram, MBBS, MRCP, Mohamad Farid, MBBS, MMed, MRCP, Tiffany Tang, MBBS, MRCP, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Soon Thye Lim, MBBS, MRCP, FAMS, Jason Yongsheng Chan, MBBS

Blood (2018) 132 (Supplement 1): 5396.

https://doi.org/10.1182/blood-2018-99-114792

Published: 2018

Journal Articles

Differential Outcomes of Synchronous and Metachronous Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma

Natalie Pei Xin Chan, Ryan Mao Heng Lim, Lay Poh Khoo, BSc, Chee Leong Cheng, FRCPA, FRCPath, MBBS, Leonard Kwan Cheong Tan, Eileen Yi Ling Poon, MBBS, MRCP, MMED, Nagavalli Somasundaram, MBBS, MRCP, Mohamad Farid, MBBS, MRCP (UK), Tiffany Tang, MBBS, MRCP, Miriam Tao, MBBS, FAMS, FHKAM, FHKCP, MRCP, Soon Thye Lim, Jason Yongsheng Chan, MBBS

Blood (2018) 132 (Supplement 1): 5409.

https://doi.org/10.1182/blood-2018-99-116231

Published: 2018

Journal Articles

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

Blood (2018) 132 (Supplement 1): 2885.

https://doi.org/10.1182/blood-2018-99-118364

Published: 2018

Journal Articles

A Patient Derived Xenograft As a Preclinical Model for Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Dachuan Huang, PhD, Wan Lu Pang, Daryl Ming Zhe Cheah, Yurike Laurensia, Jing Quan Lim, PhD, Soo Yong Tan, Tiffany Tang, MBBS, MRCP, Soon Thye Lim, Choon Kiat Ong, PhD

Blood (2018) 132 (Supplement 1): 2949.

https://doi.org/10.1182/blood-2018-99-110899

Published: 2018

Journal Articles

Whole-Genome Genomics Correlates of Response to Anti-PD1 Therapy in Relapsed/Refractory Natural Killer/T Cell Lymphoma

Jing Quan Lim, PhD, Tiffany Tang, MBBS, MRCP, Daryl Tan, MD, Yurike Laurensia, Burton Chia Kuan Hui, Bsc, Jabed Iqbal, MD, Dachuan Huang, PhD, Tammy Song, PhD, Cedric Chuan Young Ng, MSc, Huangming Hong, Rex Au-Yeung, Benjamin Mow, MD, Qichun Cai, MD, LM Poon, Yok-Lam Kwong, Jin-Xin BEI, PhD, Tongyu Lin, Soon Thye Lim, Choon Kiat Ong, PhD

Blood (2018) 132 (Supplement 1): 2915.

https://doi.org/10.1182/blood-2018-99-110900

Published: 2018

Journal Articles

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Tiffany Tang, MBBS, MRCP, Cindy Lim, Miriam Tao, MBBS, MRCP, Richard Quek, MBBS, MRCP, Mohamad Farid, Won Seog Kim, MDPhD, Seok Jin Kim, MD PhD, Seong Hyun Jeong, Jong-Ho Won, MD, Nooraisyah Ismail, Soon Thye Lim, MBBS, MRCP

Blood (2014) 124 (21): 5465.

https://doi.org/10.1182/blood.V124.21.5465.5465

Published: 2014

Journal Articles

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

Joycelyn Jie Xin Lee, MBBS, Glorijoy Shi En Tan, MBBS, Chee Hian Tan, MBBS, Summer Pan, Chiea Chuen Khor, Jianjun Liu, Jia Nee Foo, Soo Yong Tan, MBBS, MRCPath, Siok Bian Ng, Miriam Tao, MBBS, MRCP, Soon Thye Lim, MBBS, MRCP, Tiffany Tang, MBBS, MRCP

Blood (2013) 122 (21): 4249.

https://doi.org/10.1182/blood.V122.21.4249.4249

Published: 2013

Journal Articles

Prognostic Significance Of JAK3 Activating Mutations In Natural-Killer/T-Cell Lymphomas

Tiffany Tang, MBBS, MRCP, Summer Pan, Ghee Chong Koo, PhD, Soo Yong Tan, MBBS, MRCPath, Cedric Ng, Vikneswari Rajasegaran, Choon Kiat Ong, Leonard Tan, MBBS, MRCPath, Kevin Tay, MD, Miriam Tao, MBBS, MRCP, Richard Quek, MBBS, MRCP, Kheng Wei Yeoh, MD, Bin Tean Teh, MD, PhD, Soon Thye Lim, MBBS, MRCP

Blood (2013) 122 (21): 4337.

https://doi.org/10.1182/blood.V122.21.4337.4337

Published: 2013

Journal Articles

Gene Expression Profiling Identifies the JAK/STAT and NFκB Pathways to Be Important in Peripheral T-Cell Lymphomas and Natural-Killer T-Cell Lymphomas

Tiffany Tang, MBBS, MRCP, George Allen, Ghee Chong Koo, PhD, Kevin Tay, MD, Daryl Tan, MBBS, MRCP, Richard Quek, MBBS, MRCP, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Bin Tean Teh, MD, PhD, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 2658.

https://doi.org/10.1182/blood.V118.21.2658.2658

Published: 2011

Journal Articles

Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma,

Kevin Tay, MD, Gillianne Lai, Elaine J Chua, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Daryl Tan, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 3683.

https://doi.org/10.1182/blood.V118.21.3683.3683

Published: 2011

Journal Articles

Should Intensive Chemotherapy Be Required for All Mantle Cell Lymphoma Patients

Zhen Tang Lao, MBBS, MRCP, Kathleen Khoo, Jasmine Koh, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Daryl Tan, MBBS, MRCP, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP, Kevin Tay, MD

Blood (2011) 118 (21): 5188.

https://doi.org/10.1182/blood.V118.21.5188.5188

Published: 2011

Journal Articles

Follicular Lymphoma with Diffuse Large B-Cell Component At Initial Diagnosis Appears to Be Associated with a Loss of BCL2 Translocation and Inferior Progression Free Survival

Kevin Tay, MD, Yee Siang Shew, MBBS, Yu Lin Gao, Whee Sze Ong, Tiffany Tang, MBBS, MRCP, Richard Quek, MBBS, MRCP, Daryl Tan, MBBS, MRCP, Leonard Tan, MBBS, MRCPath, Miriam Tao, MBBS, MRCP, Soo Yong Tan, MBBS, MRCPath, Soon Thye Lim, MBBS, MRCP

Blood (2011) 118 (21): 1577.

https://doi.org/10.1182/blood.V118.21.1577.1577

Published: 2011

NARROW

Treatment Outcomes of Early-Stage Natural-Killer/T-Cell Lymphomas Treated with Chemoradiotherapy: Data from 3 Tertiary Cancer Centres in Singapore

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients

A Clinico-Genotypic Prognostic Index for De Novo Composite Diffuse Large B-Cell Lymphoma Arising from Follicular Lymphoma in the Rituximab Era

Differential Outcomes of Synchronous and Metachronous Diffuse Large B-Cell Lymphoma Transformed from Follicular Lymphoma

Prognostic Value of the Novel Mucosal Associated Lymphoid Tissue Prognostic Index (MALT-IPI) in Marginal Zone Lymphoma (MZL) Cases

A Patient Derived Xenograft As a Preclinical Model for Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma

Whole-Genome Genomics Correlates of Response to Anti-PD1 Therapy in Relapsed/Refractory Natural Killer/T Cell Lymphoma

A Multi-Center, Non-Randomized Phase 2 Study of Ofatumumab in Combination with ICE-Chemotherapy (O-ICE) in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Prognostic Significance Of rs6773853 Susceptibility Locus In B-Cell Non-Hodgkin’s Lymphoma

Prognostic Significance Of JAK3 Activating Mutations In Natural-Killer/T-Cell Lymphomas

Gene Expression Profiling Identifies the JAK/STAT and NFκB Pathways to Be Important in Peripheral T-Cell Lymphomas and Natural-Killer T-Cell Lymphomas

Dual Translocation Is An Independent Poor Prognostic Factor in Diffuse Large B-Cell Lymphoma,

Should Intensive Chemotherapy Be Required for All Mantle Cell Lymphoma Patients

Follicular Lymphoma with Diffuse Large B-Cell Component At Initial Diagnosis Appears to Be Associated with a Loss of BCL2 Translocation and Inferior Progression Free Survival

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only